Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 27 entries
Sorted by: Best Match Show Resources per page
Making sense of intention-to-treat.

PM & R : the journal of injury, function, and rehabilitation

Sainani KL.
PMID: 20359686
PM R. 2010 Mar;2(3):209-13. doi: 10.1016/j.pmrj.2010.01.004.

No abstract available.

Cite
Sainani KL. Making sense of intention-to-treat. PM R. 2010;2(3):209-13doi: 10.1016/j.pmrj.2010.01.004.
Sainani, K. L. (2010). Making sense of intention-to-treat. PM & R : the journal of injury, function, and rehabilitation, 2(3), 209-13. https://doi.org/10.1016/j.pmrj.2010.01.004
Sainani, Kristin L. "Making sense of intention-to-treat." PM & R : the journal of injury, function, and rehabilitation vol. 2,3 (2010): 209-13. doi: https://doi.org/10.1016/j.pmrj.2010.01.004
Sainani KL. Making sense of intention-to-treat. PM R. 2010 Mar;2(3):209-13. doi: 10.1016/j.pmrj.2010.01.004. PMID: 20359686.
Copy Download .nbib Format: NLM
Commentary: time-to-pregnancy in the Real World.

Epidemiology (Cambridge, Mass.)

Keiding N, Slama R.
PMID: 25437318
Epidemiology. 2015 Jan;26(1):119-21. doi: 10.1097/EDE.0000000000000215.

No abstract available.

Cite
Keiding N, Slama R. Commentary: time-to-pregnancy in the Real World. Epidemiology. 2015;26(1):119-21doi: 10.1097/EDE.0000000000000215.
Keiding, N., & Slama, R. (2015). Commentary: time-to-pregnancy in the Real World. Epidemiology (Cambridge, Mass.), 26(1), 119-21. https://doi.org/10.1097/EDE.0000000000000215
Keiding, Niels, and Slama, Rémy. "Commentary: time-to-pregnancy in the Real World." Epidemiology (Cambridge, Mass.) vol. 26,1 (2015): 119-21. doi: https://doi.org/10.1097/EDE.0000000000000215
Keiding N, Slama R. Commentary: time-to-pregnancy in the Real World. Epidemiology. 2015 Jan;26(1):119-21. doi: 10.1097/EDE.0000000000000215. PMID: 25437318.
Copy Download .nbib Format: NLM
Is it the intention that counts?.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Stensrud MJ.
PMID: 30917635
Tidsskr Nor Laegeforen. 2019 Mar 25;139(6). doi: 10.4045/tidsskr.18.0956. Print 2019 Mar 26.

No abstract available.

Cite
Stensrud MJ. Er det intensjonen som teller? Is it the intention that counts?. Tidsskr Nor Laegeforen. 2019;139(6)doi: 10.4045/tidsskr.18.0956.
Stensrud, M. J. (2019). Er det intensjonen som teller? Is it the intention that counts?. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 139(6), . https://doi.org/10.4045/tidsskr.18.0956
Stensrud, Mats Julius. "Er det intensjonen som teller?" Is it the intention that counts?. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke vol. 139,6 (2019). doi: https://doi.org/10.4045/tidsskr.18.0956
Stensrud MJ. Er det intensjonen som teller? Is it the intention that counts?. Tidsskr Nor Laegeforen. 2019 Mar 25;139(6). doi: 10.4045/tidsskr.18.0956. Print 2019 Mar 26. Norwegian. PMID: 30917635.
Copy Download .nbib Format: NLM
Considerations for Evaluating Treatment Effects From Randomized Clinical Trials.

Clinical pharmacology and therapeutics

Ruberg SJ, Akacha M.
PMID: 28891044
Clin Pharmacol Ther. 2017 Dec;102(6):917-923. doi: 10.1002/cpt.869. Epub 2017 Oct 09.

This article focuses on the choice of treatment effect measures in randomized clinical trials (RCTs). Traditionally, an intention-to-treat (ITT) analysis is conducted with an implicit understanding that a treatment-policy effect is of greatest interest. In this article we contend...

Cite
Ruberg SJ, Akacha M. Considerations for Evaluating Treatment Effects From Randomized Clinical Trials. Clin Pharmacol Ther. 2017;102(6):917-923doi: 10.1002/cpt.869.
Ruberg, S. J., & Akacha, M. (2017). Considerations for Evaluating Treatment Effects From Randomized Clinical Trials. Clinical pharmacology and therapeutics, 102(6), 917-923. https://doi.org/10.1002/cpt.869
Ruberg, Stephen J, and Akacha, Mouna. "Considerations for Evaluating Treatment Effects From Randomized Clinical Trials." Clinical pharmacology and therapeutics vol. 102,6 (2017): 917-923. doi: https://doi.org/10.1002/cpt.869
Ruberg SJ, Akacha M. Considerations for Evaluating Treatment Effects From Randomized Clinical Trials. Clin Pharmacol Ther. 2017 Dec;102(6):917-923. doi: 10.1002/cpt.869. Epub 2017 Oct 09. PMID: 28891044.
Copy Download .nbib Format: NLM
The Intention-to-Treat Analysis Is Not Always the Conservative Approach.

The American journal of medicine

Shrier I, Verhagen E, Stovitz SD.
PMID: 28392186
Am J Med. 2017 Jul;130(7):867-871. doi: 10.1016/j.amjmed.2017.03.023. Epub 2017 Apr 07.

No abstract available.

Cite
Shrier I, Verhagen E, Stovitz SD. The Intention-to-Treat Analysis Is Not Always the Conservative Approach. Am J Med. 2017;130(7):867-871doi: 10.1016/j.amjmed.2017.03.023.
Shrier, I., Verhagen, E., & Stovitz, S. D. (2017). The Intention-to-Treat Analysis Is Not Always the Conservative Approach. The American journal of medicine, 130(7), 867-871. https://doi.org/10.1016/j.amjmed.2017.03.023
Shrier, Ian, et al. "The Intention-to-Treat Analysis Is Not Always the Conservative Approach." The American journal of medicine vol. 130,7 (2017): 867-871. doi: https://doi.org/10.1016/j.amjmed.2017.03.023
Shrier I, Verhagen E, Stovitz SD. The Intention-to-Treat Analysis Is Not Always the Conservative Approach. Am J Med. 2017 Jul;130(7):867-871. doi: 10.1016/j.amjmed.2017.03.023. Epub 2017 Apr 07. PMID: 28392186.
Copy Download .nbib Format: NLM
Modified intention to treat reporting in randomised controlled trials: systematic review.

BMJ (Clinical research ed.)

Abraha I, Montedori A.
PMID: 20547685
BMJ. 2010 Jun 14;340:c2697. doi: 10.1136/bmj.c2697.

OBJECTIVES: To determine the incidence and characteristics of randomised controlled trials that report using the modified intention to treat approach, and how the approach is described.DESIGN: Systematic review.DATA SOURCES: PubMed, Embase, Cochrane central register of controlled trials, ISI Web...

Cite
Abraha I, Montedori A. Modified intention to treat reporting in randomised controlled trials: systematic review. BMJ. 2010;340:c2697doi: 10.1136/bmj.c2697.
Abraha, I., & Montedori, A. (2010). Modified intention to treat reporting in randomised controlled trials: systematic review. BMJ (Clinical research ed.), 340c2697. https://doi.org/10.1136/bmj.c2697
Abraha, Iosief, and Montedori, Alessandro. "Modified intention to treat reporting in randomised controlled trials: systematic review." BMJ (Clinical research ed.) vol. 340 (2010): c2697. doi: https://doi.org/10.1136/bmj.c2697
Abraha I, Montedori A. Modified intention to treat reporting in randomised controlled trials: systematic review. BMJ. 2010 Jun 14;340:c2697. doi: 10.1136/bmj.c2697. PMID: 20547685; PMCID: PMC2885592.
Copy Download .nbib Format: NLM
Only ITT analysis provides information about the actual effects of a health policy - Author response.

Journal of clinical epidemiology

Bender AM, Pisinger C, Jørgensen T.
PMID: 30423374
J Clin Epidemiol. 2019 Mar;107:125-126. doi: 10.1016/j.jclinepi.2018.11.008. Epub 2018 Nov 10.

No abstract available.

Cite
Bender AM, Pisinger C, Jørgensen T. Only ITT analysis provides information about the actual effects of a health policy - Author response. J Clin Epidemiol. 2018;107:125-126doi: 10.1016/j.jclinepi.2018.11.008.
Bender, A. M., Pisinger, C., & Jørgensen, T. (2019). Only ITT analysis provides information about the actual effects of a health policy - Author response. Journal of clinical epidemiology, 107125-126. https://doi.org/10.1016/j.jclinepi.2018.11.008
Bender, Anne Mette, et al. "Only ITT analysis provides information about the actual effects of a health policy - Author response." Journal of clinical epidemiology vol. 107 (2019): 125-126. doi: https://doi.org/10.1016/j.jclinepi.2018.11.008
Bender AM, Pisinger C, Jørgensen T. Only ITT analysis provides information about the actual effects of a health policy - Author response. J Clin Epidemiol. 2019 Mar;107:125-126. doi: 10.1016/j.jclinepi.2018.11.008. Epub 2018 Nov 10. PMID: 30423374.
Copy Download .nbib Format: NLM
Alternatives to Intention-to-Treat Analyses.

JAMA

Geldsetzer P, Bärnighausen T, Sudharsanan N.
PMID: 31162563
JAMA. 2019 Jun 04;321(21):2134-2135. doi: 10.1001/jama.2019.3092.

No abstract available.

Cite
Geldsetzer P, Bärnighausen T, Sudharsanan N. Alternatives to Intention-to-Treat Analyses. JAMA. 2019;321(21):2134-2135doi: 10.1001/jama.2019.3092.
Geldsetzer, P., Bärnighausen, T., & Sudharsanan, N. (2019). Alternatives to Intention-to-Treat Analyses. JAMA, 321(21), 2134-2135. https://doi.org/10.1001/jama.2019.3092
Geldsetzer, Pascal, et al. "Alternatives to Intention-to-Treat Analyses." JAMA vol. 321,21 (2019): 2134-2135. doi: https://doi.org/10.1001/jama.2019.3092
Geldsetzer P, Bärnighausen T, Sudharsanan N. Alternatives to Intention-to-Treat Analyses. JAMA. 2019 Jun 04;321(21):2134-2135. doi: 10.1001/jama.2019.3092. PMID: 31162563.
Copy Download .nbib Format: NLM
Alternatives to Intention-to-Treat Analyses-Reply.

JAMA

DeMets DL, Cook TD.
PMID: 31162566
JAMA. 2019 Jun 04;321(21):2135. doi: 10.1001/jama.2019.3096.

No abstract available.

Cite
DeMets DL, Cook TD. Alternatives to Intention-to-Treat Analyses-Reply. JAMA. 2019;321(21):2135doi: 10.1001/jama.2019.3096.
DeMets, D. L., & Cook, T. D. (2019). Alternatives to Intention-to-Treat Analyses-Reply. JAMA, 321(21), 2135. https://doi.org/10.1001/jama.2019.3096
DeMets, David L, and Cook, Thomas D. "Alternatives to Intention-to-Treat Analyses-Reply." JAMA vol. 321,21 (2019): 2135. doi: https://doi.org/10.1001/jama.2019.3096
DeMets DL, Cook TD. Alternatives to Intention-to-Treat Analyses-Reply. JAMA. 2019 Jun 04;321(21):2135. doi: 10.1001/jama.2019.3096. PMID: 31162566.
Copy Download .nbib Format: NLM
The same lesson over and over: drugs alone will not get us to 90--90--90.

AIDS (London, England)

Cohen J, Pepperrell T, Venter WDF.
PMID: 32028330
AIDS. 2020 May 01;34(6):943-946. doi: 10.1097/QAD.0000000000002494.

: Addressing social determinants of health (SDH) has far greater potential to improve the real-world effectiveness of HIV treatment than expensive, incremental changes in antiretroviral therapy. The ADVANCE study demonstrates that SDH is more impactful than medication regimen on...

Cite
Cohen J, Pepperrell T, Venter WDF. The same lesson over and over: drugs alone will not get us to 90--90--90. AIDS. 2020;34(6):943-946doi: 10.1097/QAD.0000000000002494.
Cohen, J., Pepperrell, T., & Venter, W. D. F. (2020). The same lesson over and over: drugs alone will not get us to 90--90--90. AIDS (London, England), 34(6), 943-946. https://doi.org/10.1097/QAD.0000000000002494
Cohen, Jennifer, et al. "The same lesson over and over: drugs alone will not get us to 90--90--90." AIDS (London, England) vol. 34,6 (2020): 943-946. doi: https://doi.org/10.1097/QAD.0000000000002494
Cohen J, Pepperrell T, Venter WDF. The same lesson over and over: drugs alone will not get us to 90--90--90. AIDS. 2020 May 01;34(6):943-946. doi: 10.1097/QAD.0000000000002494. PMID: 32028330.
Copy Download .nbib Format: NLM
Invited Commentary: Opportunities That Come With Studying the Co-Occurrence of Multiple Outcomes.

American journal of epidemiology

Haneuse S, Schrag D, Nevo D.
PMID: 32314782
Am J Epidemiol. 2020 Sep 01;189(9):982-984. doi: 10.1093/aje/kwaa031.

In almost all clinical settings, patients are at risk for multiple potential events and, in consultation with health-care providers, must weigh the potential benefits and harms across these events when making decisions. As researchers seek to build an evidence...

Cite
Haneuse S, Schrag D, Nevo D. Invited Commentary: Opportunities That Come With Studying the Co-Occurrence of Multiple Outcomes. Am J Epidemiol. 2020;189(9):982-984doi: 10.1093/aje/kwaa031.
Haneuse, S., Schrag, D., & Nevo, D. (2020). Invited Commentary: Opportunities That Come With Studying the Co-Occurrence of Multiple Outcomes. American journal of epidemiology, 189(9), 982-984. https://doi.org/10.1093/aje/kwaa031
Haneuse, Sebastien, et al. "Invited Commentary: Opportunities That Come With Studying the Co-Occurrence of Multiple Outcomes." American journal of epidemiology vol. 189,9 (2020): 982-984. doi: https://doi.org/10.1093/aje/kwaa031
Haneuse S, Schrag D, Nevo D. Invited Commentary: Opportunities That Come With Studying the Co-Occurrence of Multiple Outcomes. Am J Epidemiol. 2020 Sep 01;189(9):982-984. doi: 10.1093/aje/kwaa031. PMID: 32314782; PMCID: PMC7443758.
Copy Download .nbib Format: NLM
Demystifying intention-to-treat analyses.

JBI database of systematic reviews and implementation reports

Tufanaru C.
PMID: 28398970
JBI Database System Rev Implement Rep. 2017 Apr;15(4):853-854. doi: 10.11124/JBISRIR-2017-003383.

No abstract available.

Cite
Tufanaru C. Demystifying intention-to-treat analyses. JBI Database System Rev Implement Rep. 2017;15(4):853-854doi: 10.11124/JBISRIR-2017-003383.
Tufanaru, C. (2017). Demystifying intention-to-treat analyses. JBI database of systematic reviews and implementation reports, 15(4), 853-854. https://doi.org/10.11124/JBISRIR-2017-003383
Tufanaru, Catalin. "Demystifying intention-to-treat analyses." JBI database of systematic reviews and implementation reports vol. 15,4 (2017): 853-854. doi: https://doi.org/10.11124/JBISRIR-2017-003383
Tufanaru C. Demystifying intention-to-treat analyses. JBI Database System Rev Implement Rep. 2017 Apr;15(4):853-854. doi: 10.11124/JBISRIR-2017-003383. PMID: 28398970.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 27 entries